About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 101805, 9 pages
http://dx.doi.org/10.1155/2013/101805
Research Article

1,25-Dihydroxyvitamin D3 Inhibits the RANKL Pathway and Impacts on the Production of Pathway-Associated Cytokines in Early Rheumatoid Arthritis

1Division of Rheumatology, Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China
2Department of Medicine, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China
3Arizona Health Sciences Center, 1501 N. Campbell, Room 4104, P.O. Box 245051, Tucson, AZ 85724, USA
4University of Washington, 1410 NE Campus Parkway, 459 Schmitz Hall, P.O. Box 355832, Seattle, WA 98195-5832, USA

Received 28 January 2013; Revised 1 April 2013; Accepted 3 April 2013

Academic Editor: Gary S. Stein

Copyright © 2013 Jing Luo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jing Luo, Hongyan Wen, Hui Guo, Qi Cai, Shuangtian Li, and Xiaofeng Li, “1,25-Dihydroxyvitamin D3 Inhibits the RANKL Pathway and Impacts on the Production of Pathway-Associated Cytokines in Early Rheumatoid Arthritis,” BioMed Research International, vol. 2013, Article ID 101805, 9 pages, 2013. doi:10.1155/2013/101805